Clinical Trial Update: Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 safety study of TH9507 in adults with stable Type 2 diabetes has completed enrollment and safety assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TH9507

Snippet

Sponsor: Theratechnologies | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED